The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease

Joint Bone Spine

Volumn 71, Issue 5, 2004, Pages 365-368

  Netter, Patrick ^a   Bardin, Thomas ^b   Bianchi, Arnaud ^a   Richette, Pascal ^b   Loeuille, Damien ^a  

^a Lab Physiopathol Pharmacologie A   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

ANKH; Calcium pyrophosphate dihydrate deposition disease; Chondrocalcinosis; Growth factors; Inorganic pyrophosphate; Mutations

Indexed keywords

CALCIUM PYROPHOSPHATE; CYTOKINE; GROWTH FACTOR; PROTEIN; PROTEIN ANKH; UNCLASSIFIED DRUG;

ARTHROPATHY; CARTILAGE; CHROMOSOME 5; CHROMOSOME 8; CHROMOSOME STRUCTURE; CHRONIC DISEASE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CRYSTAL STRUCTURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXTRACELLULAR SPACE; FAMILIAL CALCIUM PYROPHOSPHATE DIHYDRATE DEPOSITION DISEASE; FAMILIAL DISEASE; FRANCE; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; HOMOZYGOSITY; HUMAN; INTRACELLULAR SPACE; METABOLISM; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; REVIEW; SYNOVIAL FLUID; UNITED KINGDOM;

EID: 5044224057     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2004.01.011     Document Type: Short Survey

References (32)

1. Hugues A.E., Mc Gibbon D., Woodward E., Dixey J., and Doherty M. Localisation of a gene for chondrocalcinosis to chromosome 5p Hum Mol Gen 4 1995 1225 1228
2. Andrew L.J., Brancolini V., de la Pena L.S., Devoto M., Caeiro F., and Marchegiani R. Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease Am J Hum Gen 64 1999 136 145
3. Bardin T, Bouchaud-Chabot A, Collange C. Les chondrocalcinoses articulaires familiales. In "l'actualité rhumatologique". Kahn MF, Kuntz D, Meyer O, Bardin T, Orcel P editors. Paris: Elsevier éd; 2003; 93-101
4. Kahn M.F., and de Sze S. Rheumatic manifestations of heritable disorders of connective tissue Clin Rheum Dis 1 1975 3 36
5. Marinescu R.C., Nyce K., de la Pena L.S., Overhauser J., and Williams C.J. Exclusion of the gene for human cartilage intermediate-layer protein in currently mapped calcium pyrophosphate dihydrate deposition syndromes Arthritis Rheum 42 1999 2139 2144
6. Ho A.M., Jonhson M.D., and Kingsley D.M. Role of the mouse ank gene in control of tissue calcification and arthritis Science 289 2000 265 270
7. Sweet H.O., and Green M.C. Progressive ankylosis, a new skeletal mutation in the mouse J Heredity 72 1981 87 93
8. Hakim F.T., Cranley R., Brown K.S., Eanes E.D., Harne L., and Oppenheim J.J. Hereditary joint disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition with inflammatory arthropathy Arthritis Rheum 27 1984 1411 1420
9. Mahowad M.L., Krug H., and Halverson P. Progressive ankylosis (ank/ank) in mice: an animal model of spondylarthropathy. II. Light and electron microscopic findings J Rheumatol 16 1989 60 66
10. Sampson H.W., and Davis J.S. Histopathology of the intervertebral disc of progressive ankylosis mice Spine 13 1988 650 654
11. Mohawad M.L., Krug H., and Taurog J. Progressive ankylosis in mice. An animal model of spondylarthropathy. I. Clinical and radiographic findings Arthritis Rheum 31 1988 1390 1399
12. Krug H.E., and Taurog J.D. HLA-B27 has no effect on the phenotypic expression of progressive ankylosis in ank/ank mice J Rheumatol 27 2000 1257 1259
13. Krug H.E., Wietgrefe M.M., Ytterberg S.R., Taurog J.D., and Mahowald M.L. Murine progressive ankylosis is not immunologically mediated J Rheumatol 24 1997 115 122
14. Hakim F.T., Brown K.S., and Oppenheim J.J. Hereditary joint disorder in progressive ankylosis (ank/ank) mice. II. Effect of high dose hydroxycortisone treatment on inflammation and intraarticular calcium hydroxyapatite deposits Arthritis Rheum 29 1986 114 123
15. Krug H.E., Mahowald M.L., Halverson P.B., Sallis J.D., and Cheung H.S. Phosphocitrate prevents disease progression in murine progressive ankylosis Arthritis Rheum 36 1993 1603 1611
16. Rosenthal A.K., and Ryan L.M. Probenecid inhibits transforming growth factor-1 induced pyrophosphate elaboration by chondrocytes J Rheumatol 21 1994 896 900
17. Okawa A., Nakamura I., and Goto S. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine Nat Genet 19 1998 271 278
18. Bardin T. Mtabolisme des pyrophosphates de Sze S. Ryckewaert A. Kahn M.F. Gurin C. L'actualit rhumatologique 1986 1986 Expansion scientifique d Paris 242 249
19. Netter P., Loeuille D., Jouzeau J.Y., Gillet P., Peterschmitt J., and Pourel J. Les chondrocalcinoses articulaires familiales: etude d'une famille alsacienne Bull Acad Nat Med 185 2001 417 426
20. Johnson M., Ho A., Mc Grath R., Netter P., Loeuille D., and Gillet P. Analysis of the ank gene reveals a heterozygous missense mutation in a French family with calcium pyrophosphate deposition disease (CPPDD) Arthritis Rheum 44 Suppl 9 2001 S161
21. Pendleton A., Johnson M.D., Hughes A., Gurley K.A., Ho A.M., and Doherty M. Mutations in the human ANKH gene are associated with adult-onset chondrocalcinosis due to calcium pyrophosphate crystal deposition Am J Hum Gen 71 2002 933 940
22. Williams C.J., Zhang Y., Timms A., Bonavita G., Caeiro F., and Broxholme J. Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH Am J Hum Gen 71 2002 985 991
23. Pendleton A., Johnston M., Ho A., Gurley K., Kingsley D., and Wright G.D. A heterozygous mutation in the human ANK gene in a British family with adult-onset chondrocalcinosis due to calcium pyrophosphate crystal deposition Arthritis Rheum 44 Suppl 9 2001 S101
24. Williams C.J., Pendleton A., Bonavita G., Reginato A.J., Hughes A.E., and Peariso S. Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease Arthritis Rheum 48 2003 2627 2631
25. Nurnberg P., Thiele H., Chandler D., Hohne W., Cunningham M.L., and Ritter H. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia Nature Gen 28 2001 37 41
26. Reichenberger E., Tiziani V., Watanabe S., Park L., Ueki Y., and Santanna C. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK Am J Hum Gen 68 2001 1321 1326
27. Lotz M., Rosen F., McCabe G., Quach J., Blanco F., and Dudler J. Interleukin 1beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes Proc Natl Acad Sci USA 92 1995 10364 10368
28. Johnson K., Vaingankar S., Chen Y., Moffa A., Goldring M.B., and Sano K. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes Arthritis Rheum 42 1999 1986 1997
29. Guo Y., Hsu D.K., Feng S.L., Richards C.M., and Winkles J.A. Polypeptide growth factors and phorbol ester induce progressive ankylosis (ank) gene expression in murine and human fibroblasts J Cell Biochem 84 2001 27 38
30. Hirose J., Ryan L.M., and Masuda I. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease Arthritis Rheum 46 2002 3218 3229
31. Rosenthal A.K., Cheung H.S., and Ryan L.M. Transforming growth factor 1 stimulates inorganic pyrophosphate elaboration by porcine cartilage Arthritis Rheum 34 1991 904 911
32. Punzi L., Oliviero F., and Ramonda R. Transforming growth factor- levels in synovial fluid of osteoarthritis with or without calcium pyrophosphate dehydrate crystals (letter) J Rheumatol 30 2003 420